New Hope Network is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Jarrow launches Baby's Jarro-Dophilus Drops

Jarrow launches Baby's Jarro-Dophilus Drops

Jarrow Formulas, a formulator and supplier nutritional supplements, announces the introduction of Baby’s Jarro-Dophilus Drops featuring one of the world’s most documented Bifidobacterium strains, Bifidobacterium BB-12.

Bifidobacteria are organisms that colonize the gut shortly after birth and are integral in the health of the adult digestive tract. Strains of bifidobacteria are known to produce healthy short-chain fatty acids, modulate immune response, and promote greater tolerance to dairy products.

“Baby’s Jarro-Dophilus Drops provides the highly documented probiotic strain Bifidobacterium BB-12 in a vegan oil matrix that is room temperature stable, NON-GMO, and allergen free,” says Rory Lipsky, Senior Director of Business Strategy.  “Baby’s Jarro-Dophilus Drops delivers 1 billion viable cells per six drops to help protect, maintain and restore a balanced intestinal microbiota in children.”

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.